Sanofi’s Enjaymo for hemolytic anemia given marketing authorization by EC
Sanofi’s treatment, Enjaymo, for hemolytic anemia in adult patients with cold agglutinin disease (CAD), has…
November 18, 2022 - 4 minutes
Autoimmune disease
Find all the latest worldwide news and in-depth articles related to autoimmune diseases. This section includes the latest research, collaboration deals, and technology advancements of biotech companies tackling autoimmune disorders.
BioSenic’s autoimmune disease platform adapting to meet unmet medical needs
BioSenic’s systemic autoimmune disease platform, originally designed by Medsenic, is now developing controlled dosages and…
November 14, 2022 - 4 minutes
Rallybio announces positive phase 1 results for drug treating PNH and gMG
Affibody’s licensee Rallybio Corporation has announced positive topline results from a phase 1 single ascending…
November 8, 2022 - 3 minutes
First patient dosed in trial to assess predictive performance of immuno-oncology therapy
The first patient has been dosed at the Macquarie University Hospital in Sydney as part…
October 26, 2022 - 3 minutes
Partnership for better understanding of Sjögren’s syndrome announced by Evotec
A molecular patient database for Sjögren’s syndrome (SjS) and systemic lupus erythematosus (SLE) is to…
October 26, 2022 - 3 minutes
Nucleome Therapeutics raises £37.5M to deliver precision medicines
U.K. biotech company Nucleome Therapeutics Limited has closed an oversubscribed £37.5 million ($42.4 million) series…
October 19, 2022 - 2 minutes
Agreement signed to advance therapy for autoimmune disease
HanAll Biopharma’s licensed partner, Harbour BioMed, has signed an exclusive sublicense agreement with CSPC NBP…
October 12, 2022 - 3 minutes
Trial starts for treatment of warm autoimmune hemolytic anemia
China-based Hutchmed has started a phase 2/3 trial of sovleplenib in adults with a disorder…
October 10, 2022 - 2 minutes
Beyond Biotech podcast 16: Adocia, Omnio, Phenomix Sciences, Tridek-One
This week, we have four guests: Olivier Soula, deputy-CEO and director of R&D at Adocia;…
September 30, 2022 - 3 minutes
Cyxone receives approval for phase 2b rheumatoid arthritis study
Swedish biotech company Cyxone has received approval from the Medical Product Agency (Office for Registration…
September 19, 2022 - 2 minutes
Tridek-One brings in €16M to develop auto-immune diseases candidates
Tridek-One SAS, a French biotech startup specialized in the research and development of CD31 agonists…
September 15, 2022 - 2 minutes
Arcutis Biotherapeutics acquires Ducentis BioTherapeutics in deal worth up to $400M
Arcutis Biotherapeutics, Inc. has entered into an agreement to acquire Ducentis BioTherapeutics Ltd., a privately…
September 8, 2022 - 4 minutes
